#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adult T-cell lymphoma/leukaemia refractory Mucopolysaccharidosis III Neurodevelopmental disorder Pseudoxanthoma elasticum Ewing's sarcoma metastatic Shprintzen-Goldberg syndrome Stargardt's disease Leukodystrophy Acute myeloid leukaemia (in remission) Metabolic disorder Stiff person syndrome Congenital absence of bile ducts Metastases to peritoneum Neuroendocrine cell hyperplasia of infancy Undifferentiated sarcoma More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Life with Disease Netherton’s syndrome – Life with Disease Inclusion body myositis – Diagnostics Toxic epidermal necrolysis – Basic Information Progressive supranuclear palsy – Basic Information Cerebral arteriovenous malformation haemorrhagic – Diagnostics Primary hyperoxaluria Small intestine leiomyosarcoma Netherton’s syndrome – Diagnostics Stevens-Johnson syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Allo-501A Bi 1291583 Autologous Microfat Dupilumab Lomustine Ro7589655 Navitoclax Mdna11 ULIXERTINIB Morphine Hydrochloride Dorocubicel Aon-D21 Pentixafor Mk-1088 ABBV-8736 Pentixafor Gallium Ga-68 Alxn1850 Amantadine Hemisulfate Mosunetuzumab Human Serum Albumin 5% More therapies…

    Learn about Your Condition

    Pleural mesothelioma Death neonatal Arteriovenous malformation Caesarean section Femoral hernia Endometrial cancer Benign neoplasm of ureter BRAF gene mutation Leiomyosarcoma metastatic Breast angiosarcoma metastatic Insulin resistance Colorectal cancer Spinal osteoarthritis Endometrial cancer stage II Skin papilloma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Effects of Avalglucosidase Alfa Enzyme Replacement Therapy in Patients with Pompe Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Avalglucosidase Alfa
    Denmark

  • Study on Axial Spondyloarthritis Treatment Using Technetium-Labeled Certolizumab Pegol for Patients with Axial Spondyloarthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Technetium (99Mtc) Certolizumab Pegol
    Belgium

  • Study on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    France

  • Study on Percutaneous Needle Fasciotomy with Methylprednisolone Acetate or Saline for Dupuytren’s Contracture in the Finger Joint

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dupuytren’s contracture
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Methylprednisolone Acetate
    Denmark

  • Study on the Safety and Effects of SQY51 for Children and Adults with Duchenne Muscular Dystrophy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Sqy51
    France

  • Study on Zoledronic Acid Following Denosumab for Osteoporosis Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Zoledronic Acid
    Denmark
Previous Page
1 … 24 25 26 27 28 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!